Elebsiran and pegylated-IFNα: Progress toward a functional cure for chronic hepatitis B. [PDF]
Battistella S, Protzer U, Forns X.
europepmc +1 more source
HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients. [PDF]
Xie Y +14 more
europepmc +1 more source
Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV Infection. [PDF]
Barbu RE +9 more
europepmc +1 more source
Comparative Efficacy of Bulevirtide, Interferons, and Nucleos(t)ide Analogs for Chronic Hepatitis Delta: A Systematic Review and Network Meta-Analysis. [PDF]
Karkra R +7 more
europepmc +1 more source
Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan. [PDF]
Nakamoto D +12 more
europepmc +1 more source
Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency: A Multicenter Retrospective Chart Review Study. [PDF]
Domínguez-González C +7 more
europepmc +1 more source
Propofol infusion in critically ill patients is not associated with mitochondrial dysfunction or altered serum interleukin levels in the early sepsis response. [PDF]
Nedel WL, Portela LV.
europepmc +1 more source
Effects of different therapeutic methods on the 90-day prognosis of patients with HBV-ACLF: A systematic review and network meta-analysis. [PDF]
Hua Y, Liu H, He Y, Liu S, Xin Y.
europepmc +1 more source
Discontinuation of nucleos(t)ide analogues after NA-induced HBsAg seroclearance: a single-center 48-week retrospective study. [PDF]
Wang YH +5 more
europepmc +1 more source

